% Expired Patents = 14.3

CIPO Patents = 1

EPO Patents = 5

Trademarks = 5

Forward Citations = 178

Loading Chart...

8 inventors (with patents filed for the assignee):

Lior Rosenberg (4 out of 30 patents)

Eilon Asculai (3 out of 10 patents)

Guy Rubin (2 out of 2 patents)

4. Marian Gorecki (2 out of 2 patents)

5. Amir Toren (2 out of 2 patents)

6. Dafna Geblinger (1 out of 1 patent)

7. Deborah Hanah Bartfeld (1 out of 2 patents)

8. Mery Kleyman (1 out of 2 patents)

9. Evgenia Lozinsky (5 patents)

7 patents: Sort by Forward Citations

1. 11382958 - Debriding composition for treating wounds (2022-07-12),

2. 10293033 - Proteolytic extract from bromelain for the treatment of connective tissue disorders (2019-05-21),

3. 9511126 - Proteolytic extract from bromelain for the treatment of connective tissue disorders (2016-12-06),

4. 8540983 - Debriding composition from bromelain and methods of production thereof (2013-09-24),

5. 8119124 - Debriding composition from bromelain and methods of production thereof (2012-02-21),

6. 7794709 - Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome (2010-09-14),

7. 7128719 - System for enhanced chemical debridement (2006-10-31),

Mediwound Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for severe burns and chronic wounds. The company's flagship product, NexoBrid, is a novel enzymatic debridement agent that has demonstrated great potential in effectively removing dead tissue in severe burns. Mediwound is committed to improving the quality of life for patients with these conditions through their groundbreaking research and development efforts.

This text is generated by artificial intelligence and may not be accurate.